
- 1D
- 1W
- 1M
- 1Y
- 5Y
- YTD
About XOMA
XOMA Corporation is a biopharmaceutical company that develops and manufactures genetically engineered protein, peptide, and antibody pharmaceuticals. The Company's medical targets include bacterial and fungal infections, infectious complications, and immunologic and inflammatory disorders. XOMA's primary drug development platform is bactericidal/permeability-increasing protein.
News
Stock Analysis

last close
$20.8
1-mo return
20.5%
3-mo return
-25%
avg daily vol.
88.97T
52-week high
39.02
52-week low
16.96
market cap.
$202M
forward pe
-
annual div.
-
roe
15.9%
ltg forecast
-
dividend yield
-
annual rev.
$41M
inst own.
60.3%